Nanoparticle-Based Drug Delivery

Research in nanoparticle-based drug delivery explores the design and application of nanoscale materials to improve how therapeutic agents are administered and utilized within the body. Investigations focus on creating novel nanoparticle formulations, such as liposomes, polymeric nanoparticles, and inorganic nanocarriers, engineered to encapsulate drugs, protect them from degradation, and target specific tissues or cells. This work examines how particle size, surface chemistry, and composition influence drug release kinetics, bioavailability, and cellular uptake. Studies also investigate methods to overcome biological barriers and enhance therapeutic efficacy while minimizing off-target effects and toxicity.

This field holds particular relevance for Arkansas's public health initiatives and its growing biotechnology sector. Research efforts contribute to the development of more effective treatments for prevalent health concerns within the state, including various cancers and chronic diseases. The creation of advanced drug delivery systems can also foster innovation in the state's pharmaceutical and medical device industries, promoting economic development and creating opportunities for specialized manufacturing and technological advancement. Understanding nanoparticle behavior in biological systems also informs strategies for addressing environmental health and safety concerns.

This area of study draws upon expertise in materials science, chemistry, biology, pharmacology, and medicine. Engagement spans multiple Arkansas institutions, fostering a collaborative environment that addresses complex challenges in drug development and clinical application. The research connects to critical fields such as cancer treatment, pharmacology, and toxicology, facilitating advancements across a broad spectrum of health-related disciplines.